EFI
MRTX

EHP Funds Inc’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

EHP Funds Inc’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,000
Closed -$1.47M – 225
2023
Q4 		$1.47M Buy
+25,000
New +$1.41M 0.53% 15

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EHP Funds Inc's MRTX Position: Q1 2024 in Review

EHP Funds Inc sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 25,000 shares — an estimated $1.47M sold.

EHP Funds Inc first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.47M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • EHP Funds Inc reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • EHP Funds Inc sold 25,000 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.47M.
  • EHP Funds Inc first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • EHP Funds Inc's Mirati Therapeutics, Inc. Common Stock position peaked at $1.47M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on EHP Funds Inc's 13F filing for Q1 2024, filed 15 May 2024.